Mylan's EpiPen Discount Won't Help Everyone
An EpiPen savings card will cover up to $300 for certain patients who have "higher out-of-pocket costs." But there's a catch.By Briana Altergott | August 25, 2016
After facing a ton of backlash this week, drugmaker Mylan has agreed to offer discounts to patients who use its EpiPens.
"As a mother, I can assure you, the last thing that we would ever want is no one to have their EpiPen due to price. Our response has been to take that immediate action of making sure everyone has an EpiPen," Mylan CEO Heather Bresch told CNBC.
The company announced in a statement Thursday it will offer a savings card that will cover up to $300 of the EpiPen 2-Pak for "patients who are facing the burden of higher out-of-pocket costs."